PerkinElmer to Present at J.P. Morgan 33rd Annual Healthcare Conference
Business Wire - Mon Dec 22, 3:05PM CST
PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the J.P. Morgan 33rd Annual Healthcare conference on Wednesday, January 14, 2015 at 2:30 pm PT at the Westin St. Francis Hotel in San Francisco.
JPM: 62.48 (unch), PKI: 43.99 (-0.06)
Varian Eyes MeVis to Enhance Imaging Components Portfolio - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 18, 11:50AM CST
The acquisition of Germany-based MeVis Medical Solutions AG will add cancer screening software to Varian Medical Systems, Inc.'s (VAR) Imaging Components product portfolio.
PHG: 29.39 (-0.06), VAR: 88.44 (+0.69), ARAY: 7.54 (+0.19), PKI: 43.99 (-0.06)
PerkinElmer Announces First Commercial Availability of Newborn Screening Test for Severe Combined Immunodeficiency (SCID) in U.S. and Canada
Business Wire - Thu Dec 18, 6:00AM CST
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the first commercially available screening test in the United States and Canada for Severe Combined Immunodeficiency (SCID), also known more commonly as "Bubble Boy" disease. PerkinElmer has received market authorization from the FDA and from Health Canada to offer the VICTOR(TM) EnLite(TM) and EnLite(TM) Neonatal TREC Kit.
PKI: 43.99 (-0.06)
Downgrade Alert for PerkinElmer (PKI)
Comtex SmarTrend(R) - Wed Dec 17, 7:08AM CST
PerkinElmer (NYSE
PKI: 43.99 (-0.06)
PerkinElmer (PKI) Closes Acquisition of Perten Instruments - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 3:00PM CST
The completion of the acquisition is not expected to have a material impact on PerkinElmer Inc.'s (PKI) results for the fourth quarter of 2014.
ICUI: 83.38 (+1.63), ABAX: 58.48 (+0.22), PKI: 43.99 (-0.06), OSUR: 10.26 (+0.25)
Global Mammography Systems Market Forecast and Opportunity Assessment 2007 - 2020
M2 - Tue Dec 16, 9:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/h2x2hm/global) has announced the addition of the "Global Mammography Systems Market Forecast and Opportunity Assessment, 2007 - 2020" report to their offering. The global mammography market is projected to be $2.8 billion by 2020 Breast cancer, one of the most common types of cancer affecting women worldwide, represents about a quarter of all cancer deaths in women. This high mortality indicates the unmet needs of patients diagnosed with breast cancer and has resulted in a surge in demand for mammography devices in developing countries and upgrade or replacement to digital mammography systems, Full Field Digital Mammography (FFDM) and 3-D mammography systems from analogue mammography systems in developed nations. Also, the acceptance of early diagnosis has increased among people as a result of enhanced breast cancer awareness, initiation of breast screening programs, evolution in technologies and steps to improve reimbursement policies by various governments. Yet factors like high risk of exposure to radiation, false diagnosis, uncomfortable procedure, risk of occurrence of interval cancer and lack of female technicians are restraining the market growth. Among mammography systems, digital mammography has the largest market in the US, Europe, Australia and Japan but it is relatively a newer technology for the underpenetrated markets for mammography, like the rest of the Asia Pacific. For the rest of APAC and other developing economies, FFDM systems would become major centers of growth in the longer run. Key Topics Covered: 1. Charts & Tables 2. Global Market for Mammography Systems Devices (2007-2020) 3. North America Market for Mammography Systems Devices (2007-2020) 4. US Market for Mammography Systems (2007-2020) 5. Canada Market for Mammography Systems (2007-2020) 6. Europe Market for Mammography Systems Devices (2007-2020) 7. France Market for Mammography Systems (2007-2020) 8. Germany Market for Mammography Systems (2007-2020) 9. Italy Market for Mammography Systems (2007-2020) 10. Spain Market for Mammography Systems (2007-2020) 11. Netherlands Market for Mammography Systems (2007-2020) 12. UK Market for Mammography Systems (2007-2020) 13. Bulgaria Market for Mammography Systems (2007-2020) 14. Russia Market for Mammography Systems (2007-2020) 15. Asia Pacific Market for Mammography Systems Devices (2007-2020) 16. Australia Market for Mammography Systems (2007-2020) 17. China Market for Mammography Systems (2007-2020) 18. India Market for Mammography Systems (2007-2020) 19. Japan Market for Mammography Systems (2007-2020) 20. Recent Events and Developments 21. Company and Product Profiles - Carestream Health - Esaote - FUJIFILM Holdings Corp. - GE Healthcare - Hitachi Ltd. - Hologic Inc. - Internazionale Medico Scientifica Srl. - Mindray Medical International Limited - PerkinElmer Inc. - Philips Healthcare - Planmed Oy - Sectra AB - Shimadzu Corp. - Siemens Healthcare - SonoCine Inc. - Toshiba Medical Systems Corp. For more information visit http://www.researchandmarkets.com/research/h2x2hm/global
MR: 26.87 (+0.30), PKI: 43.99 (-0.06), HOLX: 26.89 (+0.10)
PerkinElmer Completes Acquisition of Perten Instruments
Business Wire - Mon Dec 15, 3:05PM CST
PerkinElmer, Inc., (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company has completed its acquisition of Perten Instruments Group AB.
PKI: 43.99 (-0.06)
Medical Diagnostics, Reagents, Assays and Test Kits Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021
M2 - Mon Dec 15, 8:07AM CST
Research and Markets (http://www.researchandmarkets.com/research/267psb/medical) has announced the addition of Plunkett Research Ltd's new report "Medical Diagnostics, Reagents, Assays and Test Kits Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Medical Diagnostics, Reagents, Assays and Test Kits Manufacturing Industry (U.S.) to reach $19.2 billion by 2021. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies Comparison of Individual Top Publicly-Held Companies to Industry Averages, 2013 - Income Statements. Balance Sheets and Cash Flow Statements Companies Mentioned - Alere Inc - Bio Rad Laboratories Inc - Cepheid - Hologic GenProbe Inc - Hologic Inc - Illumina Inc - Immucor Inc - Life Technologies Corp - PerkinElmer Inc - Promega Corp For more information visit http://www.researchandmarkets.com/research/267psb/medical Source: Plunkett Research Ltd
CPHD: 53.39 (+0.51), ILMN: 186.22 (+2.72), ALR: 37.48 (+0.37), PKI: 43.99 (-0.06), HOLX: 26.89 (+0.10)
Global Mammography Market is Projected to be $2.8 Billion by 2020
PR Newswire Europe - Thu Dec 11, 9:15AM CST
LONDON and NEW YORK, December 11, 2014 /PRNewswire/ --
PKI: 43.99 (-0.06), HOLX: 26.89 (+0.10)
OncoSec Medical Collaborates with PerkinElmer and University of California, Los Angeles to Evaluate Patient-Selection Biomarker in Immunotherapy
Business Wire - Tue Dec 02, 5:02AM CST
OncoSec Medical Inc. (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced a collaboration with PerkinElmer, Inc. and the University of California, Los Angeles (UCLA) to help researchers develop biomarker tests to evaluate a patient's immune response to cancer. This research supports the ongoing shift in oncology toward therapeutic strategies that stimulate the patient's own immune defense system to combat cancer. The approach uses PerkinElmer's new imaging-based staining methods to quantitatively evaluate CD8+ T cell density in tumor biopsies.
MRK: 57.46 (+0.25), PKI: 43.99 (-0.06)
Creating Your Own Metrics To Determine Market Direction
Papa of Four - at Seeking Alpha - Mon Dec 01, 11:33AM CST
BMRN: 88.18 (+0.89), ZBRA: 78.33 (+0.25), CAG: 36.86 (-0.07), JCOM: 63.12 (-0.46), SJNK: 29.11 (-0.01), MINI: 40.62 (-0.26), CVG: 20.51 (-0.01), PKI: 43.99 (-0.06), HDY: 0.90 (-0.02), VSAT: 63.75 (-0.20), ENS: 61.66 (+0.36), PKG: 78.90 (-0.11), LUV: 41.66 (+0.68), SYKE: 23.48 (-0.13), SPY: 207.77 (+0.02), SCHL: 35.39 (+0.07), IVC: 16.80 (+0.20), ROC: 79.11 (-0.01), COG: 30.21 (-0.39), HLX: 21.74 (+0.31), NUS: 45.27 (+0.78), DIA: 180.03 (unch), BKD: 36.16 (-0.07), IPGP: 75.14 (+0.30), WFM: 48.67 (-0.40), KND: 18.21 (+0.11), ENDP: 72.10 (+0.34), STX: 68.82 (+0.17), CYH: 55.36 (+0.37), RSTI: 29.46 (+0.32), RSG: 40.83 (+0.04), GNTX: 36.81 (-0.03), BKW: 35.50 (-1.16), NFLX: 342.10 (+5.67), ARRS: 30.17 (+0.30), AMD: 2.65 (-0.02), GLD: 112.77 (+0.03), RHT: 70.92 (+0.47), BRKR: 19.50 (+0.09), HOLX: 26.89 (+0.10), PETM: 81.16 (+0.03)
Core Informatics Appoints Mary-Ann Moore As Vice President of Marketing
PR Newswire Europe - Wed Nov 26, 6:36PM CST
Core Informatics, provider of the premier cloud-based scientific informatics platform, today announced that Mary-Ann Moore has joined the company as Vice President of Marketing.
PKI: 43.99 (-0.06)
Global High Throughput Screening (HTS) Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Danaher, PerkinElmer, Sigma-Aldrich and Thermo Fisher
PR Newswire Europe - Wed Nov 26, 1:24PM CST
DUBLIN, Oct. 14, 2014 /PRNewswire/ -- Research and Markets [http://www.researchandmarkets.com/research/sfs9c2/global_high] has announced the addition of the "Global High Throughput Screening (HTS) Market 2014-2018" [http://www.researchandmarkets.com/research/sfs9c2/global_high] report to their offering.
PKI: 43.99 (-0.06)
PerkinElmer - Small But Fair Deal Will Not Move The Needle
The Value Investor - at Seeking Alpha - Wed Nov 26, 8:59AM CST
PKI: 43.99 (-0.06)
Life Sciences Tools and Services Equities Ahead of Market - Sequenom, Illumina, PerkinElmer, Affymetrix, and Waters
PR Newswire - Wed Nov 26, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: Sequenom Inc. (NASDAQ: SQNM), Illumina Inc. (NASDAQ: ILMN), PerkinElmer Inc. (NYSE: PKI), Affymetrix Inc. (NASDAQ: AFFX), and Waters Corporation (NYSE: WAT). Free research on these five companies can be accessed at:http://investor-edge.com/register. The US markets on Tuesday, November 25, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,814.94, down 0.02% and the NASDAQ Composite closed at 4,758.25, up 0.07%. The S&P 500 finished the session 0.12% lower at 2,067.03. During the trading session, five out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 793.40, up 0.07%, with the index advancing 8.30% in the previous three months. Register for your complimentary reports on these five stocks at:
SQNM: 3.59 (-0.01), ILMN: 186.22 (+2.72), PKI: 43.99 (-0.06), WAT: 114.54 (+0.21), AFFX: 9.80 (+0.05)
PerkinElmer Inks $266M Deal to Buy Perten Instruments - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 25, 12:30PM CST
The Perten Instruments buy is expected to have a minimal impact on PerkinElmer Inc.'s (PKI) adjusted earnings per share for 2014.
ICUI: 83.38 (+1.63), GWPH: 68.08 (+1.82), PKI: 43.99 (-0.06), OSUR: 10.26 (+0.25)
PerkinElmer buys Swedish analytical instrument maker
Seeking Alpha - at Seeking Alpha - Mon Nov 24, 11:59AM CST
PKI: 43.99 (-0.06)
PerkinElmer Enters into Definitive Agreement to Acquire Perten Instruments
Business Wire - Mon Nov 24, 7:30AM CST
--Strengthens Food Quality Analysis Capabilities
PKI: 43.99 (-0.06)
PerkinElmer to Present at Piper Jaffray Healthcare Conference
Business Wire - Wed Nov 19, 3:05PM CST
PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the 26th Annual Piper Jaffray Healthcare Conference on Tuesday, December 2, at 11:30 am EST at the New York Palace Hotel in New York City.
PKI: 43.99 (-0.06)